NEVER TOO OLD OLDER PEOPLE AND SUBSTANCE MISUSE - PowerPoint PPT Presentation

1 / 54
About This Presentation
Title:

NEVER TOO OLD OLDER PEOPLE AND SUBSTANCE MISUSE

Description:

Immediate Past President Drug and Alcohol Section, European Psychiatric Association ... falls, confusion, decreasing mobility, incontinence, (iatrogenesis, frailty) ... – PowerPoint PPT presentation

Number of Views:177
Avg rating:3.0/5.0
Slides: 55
Provided by: Ila58
Category:

less

Transcript and Presenter's Notes

Title: NEVER TOO OLD OLDER PEOPLE AND SUBSTANCE MISUSE


1
NEVER TOO OLD OLDER PEOPLE AND SUBSTANCE MISUSE
  • SCOTTISH DRUGS FORUM
  • GLASGOW
  • 18 November 09

2
  • Professor Ilana Crome
  • Keele University Medical School
  • Chair, WG Older Substance Misusers, RCPsych
  • Immediate Past President Drug and Alcohol
    Section, European Psychiatric Association
  • Dr Alex Baldacchino
  • Director Centre for Addiction Research and
    Education Scotland (CARES)
  • Ninewells Hospital and Medical School
  • Dundee University and NHS Fife

3
(No Transcript)
4
Overview
  • Prevalence and epidemiology
  • Treatment evidence and outcomes
  • Practical interventions

5
(No Transcript)
6
Substance misuse is
7
MYTHS ABOUT ADDICTION AND OLDER PEOPLE
  • At your age what does it matter?
  • It is just a phase - you grow out of it.
  • Its your age there is nothing you can do about
    it.
  • Illicit drug use no longer a young mans
    disease?
  • Drug use and the older person a contradiction
    in terms?

8
(No Transcript)
9
Cannabis case grandmother is spared prison
10
(No Transcript)
11
Projecting drug use among aging baby boomers in
2020? (Colliver et al 2006)
12
Prevalence
  • A snap shot of
  • general population studies and
  • clinical studies

13
Some methodological issues
  • Invisible epidemic ageism, denial by
    professionals and families, stereotypes,
    difficult diagnosis, non-specific
  • Age varies from lt55-gt75 alcohol metabolism
    declines with age and results in greater damage
  • What is a standard drink or safe limit for
    older people?
  • Other drug use prescribed, OTT, interactions
  • Terminology application of use, misuse,
    dependence
  • Medical complications without being dependent

14
Some methodological issues
  • Gender women metabolise faster more severe
    effects earlier or lower levels of drinking
    present later more comorbidity especially abuse
  • Measurement relevant, reliable, across
    substances and in combination
  • Comparability between studies - Community studies
    miss out heavier drinkers

15
Is it a problem for older people?
  • Receive most prescriptions dispensed by NHS
  • Multiple medications 1/10 receive at least one
    potentially inappropriate drug (up to 40)
    (Lechevallier-Michel et al 2004)
  • 4 times greater in women (widowed, less educated,
    lower income, poor mental and physical health,
    social isolation)
  • Psychoactive medications with abuse potential are
    being used by 1 in 4 older people (Simoni Yang
    2006)

16
Is it a problem?
  • Over the last ten years there has been an overall
    increase (numbers and rate) in older people
  • Using illicit substances and alcohol
  • Hospital admissions for poisoning, drug related
    mental disorders, alcohol related physical
    disorders
  • Drug related deaths and alcohol related deaths
  • Usually men gt women, older usually use less

17
Is it a problem?
  • Opiate dependent people do survive into old age
  • USA Lifetime prevalence rates for illicit drug
    dependence is 1 over 60s (Hinkin 2002)
  • Alcohol consumption in GP (Hajat et el 2004) 5
    men drinking 2.5 women over benchmarks
  • Older opioid maintained patients Lofwall et al
    2005 later in life, more medical problems, worse
    general health than younger
  • Both groups had high rates of lifetime
    psychiatric illness and substance use disorder
    and poor general health compared to general
    population

18
Health conditions among ageing addicts Hser et al
2004
  • 108 survivors 58.4 years (33 year cohort)
  • Used heroin for 29.4 years
  • Current use 84 used cigarettes, 17.6 drank
    alcohol daily, 23 heroin, 21 marijuana, 11
    cocaine. 6 amphetamines
  • 51 hypertension, 22 hyperlipidemia
  • 13 elevated blood glucose, 50 overweight
  • 33 abnormal pulmonary function

19
Health status
  • 50 abnormal liver function
  • 94 tested positive for Hep C, 86 for Hep B,
    3.8 for syphilis and 27 for TB
  • Perceived themselves as having worse physical
    functioning, worse emotional well being, less
    energy and worse general health when compared to
    the general population
  • Probably conservative estimates

20
Older opiate addicts (Sidhu et al 2007) Health
Problems
21
Results Profile of Older Opiate Misuser in
Stoke-On-Trent
  • Age range gt50 years
  • 95 of cohort were white Caucasian males
  • 85 were single at time of study 50 had
    separated/divorced by age 35yrs.
  • Limited education 65 had no qualifications 30
    had between 4-9 O levels.
  • 90 were currently unemployed 10 have never
    been in employment.

22
Results Substance Misuse History
  • Lifelong polydrug users
  • Licit drugs Nicotine (100 of cohort)
  • Alcohol (47)
  • Illicit drugs Cannabis (75), Amphetamines
    (60), Crack (50), Hallucinogens (20)
  • Current substance use Cannabis (55), Crack
    (35) and Benzodiazepines (35)

23
Results Opiate Misuse History
  • Opiate use was usually started in late 20s
  • Average age first exposed to heroin 29.8 years
    (range 16-46 years SD8.8years)
  • Average length of heroin use 18.5 years (range
    6-38 years SD-8.7years)
  • In 20 of cases a major life event had occurred
    prior to using heroin

24
Results Diverse Range of Health Problems
  • Special health needs highlighted Present
    in study
  • in national guidelines
  • Infectious disease
  • Hepatitis C v (67)
  • Hepatitis B v (50)
  • HIV X ( 0 -
    only 10 tested)
  • Medical
  • Respiratory disease v (25)
  • Diabetes v
    (10)
  • Not mentioned Musculoskeletal
    pain (35)

25
Health problems
  • Special health needs highlighted Present
    in study.
  • in national guidelines
  • Cardiovascular
  • P.E./D.V.T v (25)
  • Hypertension X ( 0)
    (Inadequate information)
  • Cardiac valve destruction X (0) (No
    documentation)
  • Psychiatric
  • Self harm v
    (42)
  • Depression v (40)
  • Memory loss v (25)

26
Special health needs
  • Despite the complaint of memory loss in 25 of
    cohort, in only 1 patient was mini mental state
    examination documented.
  • 40 sample with a respiratory complaint did not
    have a diagnosis or treatment plan.
  • 55 of cohort had no documentation of Hepatitis B
    and C status.
  • 15 sample were receiving opiate analgesia for
    musculoskeletal pain.

27
Results Treatment Outcomes
  • Positive outcomes
  • Methadone maintenance programme 50 in treatment
    for over 3 years.
  • The present mean average dose was 51mls of
    methadone, but range of doses varied between
    25mg/ml-94mg/ml.
  • All reported reduction in quantity of heroin used
  • In 60 of the group who were using 300/week
    prior to treatment, amount spent reduced to
    20/week.
  • Reduction in intravenous administration whilst in
    treatment (70 to 5).
  • Negative outcome
  • Only 22 showed consistently negative opiate
    urine samples in the previous 6 months.

28
Discussion
  • This is the first study of this kind in the UK
  • Treatment is associated with positive outcomes
  • The older substance misuser has a diverse range
    of health problems i.e. physical and psychiatric
  • All special health needs may not have been
    identified as there was no routine screening
  • Where they identified, they were
  • Not appropriately further assessed investigated
    monitored
  • Not treated by a comprehensive multidisciplinary
    team in liaison with other health practitioners

29
Conclusions
  • Study has substantiated the special health needs
    which older substance misusers experience
  • Current national guidance does not provide
    evidence based management specific to older
    opiate users
  • UK guidance appropriate for this group needs
    further development in terms of4
  • Screening assessment
  • Specific treatment regimes medication licences
  • Service delivery in multidisciplinary teams (e.g.
    geriatricians, old age psychiatrists,
    psychologists, physiotherapists)



30
Recommendations Good practice clinical
governance issues
  • Supportive non-confrontational by trained
    personnel who can prevent ridicule
  • Inaccessible homebound, transportation, rural
  • Create a safe environment, financial problems
  • Explanations simple, content age specific, pace
  • Literacy and language, and sensory, needs

31
Recommendations Good practice
  • Implementation of what works in adults
  • Adaptation - addiction and old age services
  • Evidence base for the older age group length,
    dosage, type of intervention
  • Development of protocols and care plans
  • Innovation
  • Flexible, adaptive, optimistic and long term

32
Recommendations Assessment
  • A thorough, ongoing assessment which includes a
    comprehensive history
  • Many tools for screening, assessment and
    monitoring outcome but for adults
  • Neurocognitive impairment
  • Semi-structured interviews increase
    identification
  • Severity of substance use, misuse and dependence.
  • Substance use and mental disorders

33
Assessing elderly patients (Parker, Hospital
Doctor 26 4 07, and Crome personal communication!)
  • Guard against clinical ageism not an indicator
    of ability to function, benefit from treatment,
    quality of life
  • Comprehensive geriatric assessment is key to
    effective practice
  • Functional assessment is a useful clinical tool
  • Geriatric medicine oriented towards problems (but
    must not neglect diagnosis)
  • Dont write poor historian consider reasons
    for poor history eg hearing aid, confusion

34
Recommendations
  • Social admission is a myth and not a medical
    diagnosis
  • Understand geriatric giants falls, confusion,
    decreasing mobility, incontinence, (iatrogenesis,
    frailty)
  • Manage underlying cause
  • Learn to recognise delirium
  • Drug therapy is often the cause of symptoms

35
Instruments
  • G-MAST - Geriatric version of MAST gt5 positive
    MAST, SMAST, B-MAST (Michigan Alcohol Screening
    Test)
  • SMAST-G shorter version of the G-MAST
  • CAGE - 4 questions gt2 positive (Hinkin 2002)
  • Alcohol related problems survey for older people
    (ARPS) and Short ARPS (shARPS)
  • AUDIT (Alcohol use disorders test) or AUDIT -5
    (Philpot et al 2003)
  • MAST-G and CAGE most appropriate Beullens et al
    2004
  • NO VALIDATED INSTRUMENTS FOR DRUG MISUSE

36
Recommendations Critical issues in treatment
  • What is an appropriate treatment goal?
  • What is motivation for psychological change?
  • Regularity and credibility of medical advice?
  • How appropriate are techniques for assessment,
    advice, assistance? IT, telephone, larger print
  • Ask Assess Advise Assist Prescribe Arrange!
  • Adequate fluids, eating as soon as possible
  • Anti-epileptics and anti-emetics rarely required

37
NICE guidelines and others
  • Psychosocial interventions
  • Opioid detoxification
  • Methadone and burprenorphine
  • Naltrexone
  • Community interventions in vulnerable substance
    misusers
  • Department of Health Orange book 2007
  • SIGN guidelines Scotland
  • By and large comorbidity and vulnerable age
    groups are
  • excluded

38
Pharmacological treatment
39
Pharmacological treatment options
  • Drugs not investigated/licensed for over 65s
  • Benzodiazepines caution due to accumulation but
    need to give enough to cope with withdrawal
  • Acamprosate, disulfiram and naltrexone with
    utmost caution
  • Methadone and buprenorphine supervised
  • Nicotine replacement and bupropion if not C/A

40
OUTCOME STUDIES OLDER PEOPLE
  • Do older people recover?

41
Systematic Review of Treatment for Older People
Substance Problems
  • Ishbel Moy
  • Martin Frisher
  • Peter Crome
  • Ilana Crome
  • School of Medicine and School of Pharmacy
  • Keele University

42
Search Strategy
  • Search conducted May/June 2007, information from
    each study collated and tabulated, report written
    June/July 2007
  • PubMed, The Cochrane Library, MEDLINE, Project
    CORK, and EMBASE searched up to January 2007
  • Studies generated from expert consensus papers or
    advisors
  • Keywords included elderly older people
    addiction substance misuse substance abuse
    treatment alcohol nicotine smoking cessation
    prescription medications benzodiazepines
    illegal drugs illicit drugs

43
Inclusion Criteria
  • 1 Older defined as 50 years.
  • 2 Substances
  • - alcohol
  • - nicotine
  • - prescription medications
  • - illicit drugs
  • 3 Trials focussing on older people specifically
  • 4 Trials comparing older with younger
  • 5 Pharmacological and psychological treatments
    for addiction

44
Studies Included
  • 2500 titles generated.
  • 50 studies thought to be appropriate and full
    articles obtained.
  • 16 studies fulfilled inclusion criteria
  • - 9 on alcohol misuse
  • - 2 on treatment of alcohol and drug misuse
    (grouped with alcohol misuse for analysis)
  • - 3 on smoking cessation
  • - 1 on methadone maintenance
  • - 1 on prescription medications

45
Evidence - Review of 16 studies on older
substance misusers
  • Current evidence based guidance does not include
    over 50s
  • Mainly alcohol (11) smoking (3) opiates (1) and
    prescription drugs (1) in over 50s
  • 2 studies in the UK
  • Some in services for older people some in mixed
    age services
  • Almost all treatments were variety of
    psychological interventions

46
Results
  • Time period 1984-2001 14 of these after 1990.
  • Country 13 in US, 2 in UK, 1 in Canada.
  • Settings 5 studies conducted in primary care, 4
    in outpatient setting, 1 inpatient
  • Sample size 24 to 3,622 some of the larger
    studies had a relatively small proportion of
    adults in older age range.

47
  • Demographic information
  • - Age cut-off for older varied, from 50
    years and 65 years.
  • - Majority of participants in 14 studies were
    male other 2 were 93 and 100 female.
  • - 6 studies gt70 Caucasian participants.
  • Ethics approval 6 studies described ethical
    approval or exemption.

48
Results
  • Measures
  • - e.g. baseline quantity/frequency time-line
    follow-back addiction severity index (ASI) Beck
    Depression Inventory physical and psychiatric
    problems.
  • - e.g. outcome ASI abstinence drinks/day
    health status formal/informal aftercare

49
Results
  • Design 5 studies contained a control group.
  • Programmes
  • Elder-specific programs or examined older
    patients in 7 studies
  • Older patients treated in adult addiction
    programs and compared with younger age groups in
    8 studies
  • 1 compared outcomes of older adults in both
    elder-specific and adult addiction programs.

50
Overview of Study Findings - Alcohol
  • Number of patients who achieve their follow-up
    goal is at least comparable to that of other
    populations.
  • .
  • Those patients in elder-specific treatment appear
    to improve across a wide variety of outcome
    domains.
  • Brief Advice and Motivational Enhancement are
    equally successful for both older and adult
    populations.

51
Overview of Study Findings - Alcohol
  • Potential for good outcomes in those older people
    who seek treatment possible they may have
    achieved even better outcomes in an
    elder-specific program.
  • Both older men and women are capable of achieving
    abstinence if given access to alcohol abuse
    programs.
  • Value in treating older adults and that they are
    able to respond positively to treatment, but that
    there was a lack of knowledge on long-term
    management.

52
Overview of Study Findings Smoking, Heroin,
Prescription Medications
  • Smoking
  • Intervention with the nurse practitioner led to a
    decrease in smoking.
  • Older smokers appeared to benefit as much as
    younger smokers from brief office-based
    counselling.
  • .
  • Heroin
  • Older patients might have fewer problems and do
    very well in treatment for heroin dependence.
  • Prescription Drugs
  • Participation was associated with a significant
    reduction in benzodiazepine, narcotic and overall
    prescription use the reduction in health care
    utilisation observed may translate to savings in
    health care costs.

53
THE WAY FORWARD the ABC
  • Advocacy, attitudes
  • Better, appropriate treatment
  • Care, risk, resilience, recovery
  • Dignity, integrity, quality
  • Enthusiasm for evidence
  • Further research
  • Generational training, partnership working
  • High priority value older people

54
Thanks to colleagues
  • Dr Roger Bloor
  • Prof Peter Crome
  • Drs Ishbel Moy Harvinder Sidhu
  • And many other collaboratorssorry not to mention
    by name
Write a Comment
User Comments (0)
About PowerShow.com